Clinical Trials Logo

Ischemic Stroke clinical trials

View clinical trials related to Ischemic Stroke.

Filter by:

NCT ID: NCT03669653 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke

SERIC-AIS
Start date: June 17, 2024
Phase: N/A
Study type: Interventional

he purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for acute ischemic stroke.

NCT ID: NCT03252626 Not yet recruiting - Stroke Clinical Trials

Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

Start date: April 18, 2024
Phase: Phase 4
Study type: Interventional

Ischemic stroke has a variety of treatments and currently drug therapy is one of the main treatments.A number of clinical studies have proved that alprostadil (PGE1) has pharmacological effects of significant dilation of blood vessels, inhibition of plate aggregation, anti-atherosclerosis and increased cerebral blood flow.Evaluate the 90-days efficacy by comparing two groups of patients'(one with alprostadil,another with placebo) mRS.

NCT ID: NCT03246607 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation

Start date: January 26, 2020
Phase:
Study type: Observational

This study evaluates the validity of an intravascular continuous glucose monitoring microdialysis probe, and compares the values to routinely inserted cerebral glucose microdialysis to evaluate the hypothesised relationship between intracranial and intravascular glucose levels.

NCT ID: NCT03223220 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Quelling of Excitotoxicity in Acute Stroke With Ketamine

QUEST-KETA
Start date: July 1, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators plan to undertake a phase II study to investigate the efficacy and side effects of intravenous ketamine to reduce neuroexcitotoxicity, and thus provide neuroprotection in patients diagnosed with acute ischemic stroke.

NCT ID: NCT03219645 Not yet recruiting - Ischemic Stroke Clinical Trials

Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke

GDPRS
Start date: July 15, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(300mg loading dose,then 100mg once/day D2-D14) in combination, while the other half will receive aspirin(300mg loading dose,then 100mg once/day D2-D14).

NCT ID: NCT03152799 Not yet recruiting - Ischemic Stroke Clinical Trials

Remote Ischaemic Conditioning in Endovascular Recanalization for Proximal Anterior Circulation Occlusion Study

RICE PAC
Start date: August 1, 2017
Phase: Phase 1
Study type: Interventional

Ischaemic stroke causes significant morbidity and mortality and is a leading cause of disability within an ageing United Kingdom (UK) population. Proximal anterior circulation occlusion is associated with a particularly poor prognosis, but its management has undergone a paradigm shift following clinical introduction of endovascular recanalization, establishing rapid reperfusion of the ischaemic penumbra. Remote ischaemic conditioning (RIC) is highly effective at attenuating cerebral infarction in basic research studies and has the potential to further improve patient outcome if used as an adjunct to invasive revascularisation strategies. We aim to trial remote ischaemic conditioning at the time of revascularisation, and then daily for the duration of the seven-day in-patient stay, compared to a sham conditioning procedure. This pilot, single-centre study will determine efficacy/ tolerability of RIC to reduce cerebral infarction (primary endpoint: determined by brain magnetic resonance imaging [MRI]) and improve functional status (secondary end-points: National Institutes of Health Stroke Severity (NIHSS); European Quality of Life questionnaire EurQoL), with the data providing the necessary parameters for power calculations and leveraging charitable funding for a subsequent multi-centre study.

NCT ID: NCT03075137 Not yet recruiting - Ischemic Stroke Clinical Trials

Effect of External Counter Pulsation on Ischemic Stroke

Start date: June 10, 2018
Phase: Phase 3
Study type: Interventional

Stroke is a prevalent atherosclerosis vascular disease with high mortality, external counter pulsation (ECP) is an approved noninvasive therapy for angina, congestive heart failure, myocardial infarction, and cardiogenic shock that augments blood flow to cardiac and systemic circuits, which improves the flow volume in the carotid. Though ECP is Ⅱa recommendation for stroke management, no multi-center control clinical study has been reported for prognosis of stroke. The aim of this study is to evaluate the effect of ECP on stoke. To address this assumption, investigators enroll subjects with ischemic stroke and randomized into control or ECP group, the ECP intervention will be carried out with a standard protocol which involves 35 one-hour sessions (5 days a week) for continuous 7 weeks. The primary endpoint is mRS score in 3 months, secondary endpoints include NIHSS, BI and MMSE score, recurrence of stroke in 3 months, glycolipid metabolism, transcranial doppler (TCD) flow velocities and endothelial function.

NCT ID: NCT02850198 Not yet recruiting - Ischemic Stroke Clinical Trials

A Randomized Controlled Study of the Effectiveness of Scalp Electroacupuncture in Improving Upper Limb Motor Function in Convalescent Phase of Ischemic Stroke.

Start date: August 2016
Phase: N/A
Study type: Interventional

This research is primary to compare effectiveness of scalp electroacupuncture and scalp acupuncture on motor function of the upper limb(UL) in convalescence phase of ischemic stroke. The clinical research is a randomized controlled trial (RCT),consisting of two arms of scalp electroacupuncture group and sham sclp electroacupuncture group to value difference of upper limb function after 4 weeks. The result indicates that scalp electroacupuncture is more sufficient to alter function. The purpose is to value effectiveness of scalp electroacupuncture on motor function of the upper limb in convalescence phase of ischemic stroke.

NCT ID: NCT02756494 Not yet recruiting - Ischemic Stroke Clinical Trials

Ischemic Stroke in Chinese Young Adults

Start date: April 2016
Phase: N/A
Study type: Observational

Stroke is the fifth leading cause of death in the United States and the leading cause of disability. However, in China, stroke is one of the most frequent causes of death and chronic disability. Ischemic strokes in adults younger than 45 years of age were regarded as a relatively uncommon event in the proportion of <5% of all ischemic strokes.

NCT ID: NCT02454166 Not yet recruiting - Ischemic Stroke Clinical Trials

The Analysis of Chinese Medical Syndromes Differentiation on Acute Ischemic Stroke

Start date: May 2015
Phase: N/A
Study type: Observational

Background and objective: Stroke, which means sudden onset of cerebral vascular accident. The earliest document was found in "Neijing". The ancient physicians had different opinions and points of view on the etiology and pathogenesis of stroke. Before the Tang and Song dynasty, the "exopathic wind" theory was talked about. And, after then, the "endogenous wind" theory was put forward. While in the Ming dynasty, Zhang Jing-Yue advocated that "Stroke is not caused by wind etiology'', highlighting the much difference of the thinking. Until nowadays, many famous physicians have their own unique way to determine the etiologic factor based on differentiation. To be practical, objectivity differentiating and determining the etiologic factor of stroke is the foundation of establishing the treatment guidelines. The investigators aim to establish the scientific epidemiological standard of traditional Chinese Medicine (TCM) syndromes of acute ischemic stroke in Taiwan.